查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493352

美國生物感測器市場規模、佔有率、趨勢分析報告：按技術、按應用、按最終用途、細分市場預測，2024-2030 年

U.S. Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application (Medical, Food Toxicity, Bioreactor), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國生物感測器市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，預計到2030年美國生物感測器市場規模將達到156.1億美元，預計2024年至2030年複合年成長率為7.13%。

該市場包括用於醫療保健、食品安全、環境監測、農業、生物技術和安全等多個行業的各種生物感測器設備、組件、技術和服務。

由於多種因素的綜合作用，美國市場正在經歷顯著成長。關鍵促進因素之一是對就地檢驗(POCT) 解決方案的需求不斷成長，這些解決方案可在傳統實驗室之外提供快速、方便的診斷功能。

生物感測器在這些疾病狀態的診斷、監測和管理中發揮關鍵作用，推動了對創新生物感測器解決方案的需求。對生物感測器技術的監管支持和核准以及對個人化醫療的日益重視也有助於市場擴張。例如，FDA核准的FoundationOne CDx 測試是一種伴同性診斷，它使用次世代定序來檢測可能受益於標靶治療的晚期癌症患者。該測試使用生物感測器來檢查腫瘤 DNA，並提供可解決的基因組變化的詳細資訊。

美國生物感測器市場報告亮點

  • 從技術來看，電化學領域以2023年最大的收益佔有率（72.86%）引領市場。由於它們在各個領域和行業的廣泛用途，這些生物感測器可以小型化並整合到攜帶式設備中，例如個人血糖儀，可以快速測量血糖值以進行個人血糖值管理。
  • 從應用來看，由於快速且準確的診斷工具、對個人化醫療的重視、醫療保健技術的進步等，醫療產業在 2023 年以 65.57% 的最大收益佔有率引領市場。例如，2021年11月，專注於數位生物標記解決方案的美國公司Quanterix宣布發表Simoa超靈敏生物感測器平台。該平台能夠檢測與各種疾病相關的低豐度生物標記。
  • 按最終用途分類，由於診所、藥房和急診等各種環境的需求，PoC（即時護理）測試領域在 2023 年以 47.67% 的最大收益佔有率引領市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國生物感測器市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國生物感測器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國生物感測器市場：技術預估與趨勢分析

  • 2023年及2030年技術市場佔有率
  • 細分儀表板
  • 美國生物感測器市場技術展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 熱感的
  • 電化學
  • 壓電
  • 其他

第5章美國生物感測器市場：應用預估及趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 美國生物感測器市場前景（按應用）
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫療保健
  • 食品毒性
  • 反應器
  • 農業
  • 環境
  • 其他

第6章美國生物感測器市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的美國生物感測器市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 家庭保健診斷
  • 概念驗證測試
  • 食品工業
  • 研究實驗室
  • 安全和生物防禦

第7章美國生物感測器市場：區域估計和趨勢分析

  • 2023 年和 2030 年按地區分類的市場佔有率佔有率
  • 美國生物感測器市場區域展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 西
  • 中西部
  • 東北
  • 西南
  • 東南

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • Abbott
    • Medtronic
    • Hoffmann-La Roche Ltd
    • Dexcom, Inc.
    • SENTINEL
    • Intricon Corporation
    • Quanterix
    • Koninklijke Philips NV
    • Masimo
    • Siemens Healthcare Private Limited
    • Molecular Devices, LLC.
    • Johnson &Johnson Services, Inc.
    • Thermo Fisher Scientific Inc.
    • PerkinElmer Inc.
    • Covaris, LLC
Product Code: GVR-4-68040-281-8

U.S. Biosensors Market Growth & Trends:

The U.S. biosensors market size is anticipated to reach USD 15.61 billion by 2030 and is projected to grow at a CAGR of 7.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. It encompasses various biosensor devices, components, technologies, and services used across multiple industries, such as healthcare, food safety, environmental monitoring, agriculture, biotechnology, and security.

The U.S. market is experiencing significant growth driven by a combination of factors. One key driver is the increasing demand for point-of-care testing (POCT) solutions, which offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings.

Biosensors play a crucial role in diagnosing, monitoring, and managing these conditions, driving demand for innovative biosensor solutions. Regulatory support and approvals for biosensor technologies and a growing emphasis on personalized medicine are also contributing to market expansion. For instance, the FoundationOne CDx test, approved by the FDA, is a companion diagnostic utilizing next-generation sequencing to detect advanced cancer patients who could potentially benefit from targeted therapies. The test uses biosensors to examine tumor DNA to provide details on actionable genomic alterations.

U.S. Biosensors Market Report Highlights:

  • Based on technology, the electrochemical segment led the market with the largest revenue share of 72.86% in 2023, due to its diverse use across various sectors and industries, these biosensors can be miniaturized and integrated into portable devices such as personal glucose meter that provides fast measurement of blood glucose levels for personal glycemic management
  • Based on application, the medical segment led the market with the largest revenue share of 65.57%in 2023, due to the rapid and accurate diagnostic tools, emphasis on personalized medicine, advancements in healthcare technology, and others. For instance, in November 2021, Quanterix, a U.S.-based company specializing in digital biomarker solutions, announced the release of its Simoa Ultra-Sensitive Biosensors Platform. This platform empowers the detection of low-abundance biomarkers associated with various diseases
  • Based on end-use, the point of care (PoC) testing segment led the market with the largest revenue share of 47.67% in 2023, due to their demand in various settings including clinics, pharmacies, and emergency departments

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Biosensors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Biosensors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Biosensors Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. biosensors market By Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Thermal
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Electrochemical
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Piezoelectric
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Optical
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Biosensors Market: Application Estimates & Trend Analysis

  • 5.1. Product Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. biosensors market By Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Medical
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Food Toxicity
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Bioreactor
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Agriculture
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Environment
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Biosensors Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Biosensors Market By End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Home healthcare diagnostics
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. PoC testing
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Food industry
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Research Laboratories
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Security and Bio-defense
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Biosensors Market: Region Estimates & Trend Analysis

  • 7.1. Regional Market Share, 2023 & 2030
  • 7.2. U.S. Biosensors Market by Region Outlook
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.3.1. West
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Midwest
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Northeast
      • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Southwest
      • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.5. Southeast
      • 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Hoffmann-La Roche Ltd
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Dexcom, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. SENTINEL
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Intricon Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Quanterix
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Masimo
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Siemens Healthcare Private Limited
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Molecular Devices, LLC.
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Johnson & Johnson Services, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Thermo Fisher Scientific Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. PerkinElmer Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Covaris, LLC
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. biosensors market, by technology, 2018 - 2030 (USD Million and Volume Unit)
  • Table 3 U.S. biosensors market, by application, 2018 - 2030 (USD Million and Volume Unit)
  • Table 4 U.S. biosensors market, by end-use, 2018 - 2030 (USD Million and Volume Unit)
  • Table 5 U.S. biosensors market, by region, 2018 - 2030 (USD Million and Volume Unit)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. biosensors market: Market outlook
  • Fig. 9 U.S. clinical trial supplies competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. biosensors market driver impact
  • Fig. 14 U.S. biosensors market restraint impact
  • Fig. 15 U.S. biosensors market: Technology movement analysis
  • Fig. 16 U.S. biosensors market: Technology outlook and key takeaways
  • Fig. 17 Thermal market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 18 Electrochemical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 19 Piezoelectric market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 20 Optical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 21 U.S. biosensors market: Application movement Analysis
  • Fig. 22 U.S. biosensors market: Application outlook and key takeaways
  • Fig. 23 Medical market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 24 Food toxicity market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 25 Bioreactor market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 26 Agriculture market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 27 Environment market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 29 U.S. biosensors market: End-use movement analysis
  • Fig. 30 U.S. biosensors market: End-use outlook and key takeaways
  • Fig. 31 Home healthcare diagnostics market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 32 PoC Testing market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 33 Food industry market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 34 Research laboratories market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 35 Security and bio-defense market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 36 U.S. pediatric home healthcare market: Regional movement analysis
  • Fig. 37 U.S. pediatric home healthcare market: Regional outlook and key takeaways
  • Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)